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Substantial effort has been applied to researching government initiatives aimed at increasing 
efficiency and cost effectiveness within the UK healthcare system, particularly in terms of 
medical practice. However, little attention has been paid to the impact of these on the 
boundaries of authority within the setting of hospital pharmacies. This paper utilises the 
sociology of the professions to analyse and report on hospital pharmacist prescribing in 
Scotland. The findings indicate a reduction in the authority of the medical profession and that 
medical practice can be subjected to rationalisation in the same way as other occupations which 
is of sociological importance. 
 




Over the last four decades, financial constraints and reforms of the UK’s National Health 
Service (NHS), driven by managerial and accounting logics aimed at controlling healthcare 
expenditure, have put considerable pressure on the medical profession to reconfigure 
professional roles and competencies (Martin, Currie & Finn, 2009; Jackson et al., 2014).  
Indeed, a persistent theme of NHS reform has been an attempt to improve efficiency and value 
for money through workforce reconfigurations that maximise the specialist expertise of 
professions allied to medicine, such as pharmacy (Audit Commission, 1994; DOH, 2000a, 
2000b, 2005 & 2008). In the year 2000, the Department of Health (DOH) asserted that ‘NHS 
staff, at every level, are the key to reform … [and it] is about working smarter to make 
maximum use of the talents of all the NHS workforce’ (DOH, 2000a, p.82). As a result of this 
initiative, pharmacists in the hospital setting have become integral actors within healthcare 
teams, increasingly taking on more authoritative roles and clinical responsibilities including 
greater authority over prescribing practice (DOH, 2003, 2004, 2007 & 2008; Weiss & Sutton, 
2009). Theorists of the profession argue that such role reconfigurations can enhance the 
professional status of one group (e.g. pharmacists), but will inevitably have a 
deprofessionalisation effect on another (e.g. clinicians), which is unlikely to go uncontested 
(Britton, 2001; Ritzer & Walcak, 1982). Indeed, the sociology of the professions literature 
reveals that the medical profession tends to vigorously defend its jurisdiction and professional 
boundaries (Abbott, 1988). 
 
A defining feature of a professional is their level of autonomy (Abbott, 1988), and prescribing 
has been identified as one of the key hallmarks of the medical profession and as an aspect of 
their professional jurisdiction (Larson, 1977). Indeed, within the wider structures of society, 
the monopoly over prescribing has been an indicator of the medical profession’s clinical 
autonomy and power, with full jurisdiction for prescribing being the held within the domain of 
medicine (Freidson, 1970; Mesler, 1991; Buckley, Grime & Blenkinsopp, 2006). Pharmacist 
prescribing, therefore, represents a shift in this jurisdiction, which has the potential to alter both 
professional status and interprofessional relationships. While the expansion of non-medical 
prescribing through pharmacist and nurse prescribingi may not yet have impacted significantly 
on overall medical control, it has created interprofessional boundary tensions, struggles for 
professional autonomy, (Freidson, 1994; Connelly, 2005; Abraham, 2009; Weiss & Sutton, 
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2009) and has provided the conditions for a re-stratification within healthcare professions 
(Martin, Currie & Finn, 2009). However, little attention has been given to the impact of 
attempts to improve efficiency and value for money through workforce reconfigurations such 
as pharmacist prescribing that maximise specialist expertise. This is surprising given that 
medicines constitute the principle non-surgical intervention in healthcare provision. Likewise, 
sociological investigation into the social context and interprofessional relationships of 
healthcare professionals has tended to overlook pharmacists, favouring the medical profession 
as the primary area of interest (Anderson, 2005). Such work has also tended to overlook the 
historical position of pharmacy as a strong profession, portraying it instead as a marginal or 
quasi-profession.  
 
Some studies have demonstrated that the medical profession have been responsive to the intro-
duction of managerial logics and workforce reconfigurations, but these have tended to be in 
areas that have little impact on their clinical autonomy and jurisdiction (Allan, 2001). On the 
other hand, a much larger body of literature shows considerable resistance from the medical 
profession against managerial intrusions that have the potential to affect their jurisdictional 
boundaries and professional autonomy (Martin, Currie & Finn, 2009; Drennan et al., 2017). 
However, the impact of managerial logics and workforce reconfiguration on prescribing prac-
tice in the hospital setting has previously not been examined. The aim of this study is to con-
tribute to filling this gap by investigating the changing status of pharmacists as professionals 
and its evolving interprofessional relationship with the medical profession following manage-
rial reforms that extend prescribing authority into their function. 
 
The paper begins with a brief outline of the historical position of pharmacy as a profession and 
the development of hospital pharmacy today to demonstrate the (re-)professionalisation of 
pharmacists. Following this the research approach and data analysis are put forward. The study 
findings are then presented. Through an interpretative framework the study findings are 
evaluated. Drawing on the accounts of pharmacists and clinicians highlights a change in 
perceptions of the professional status of both groups due to workforce reconfigurations arising 
from managerial logics being imposed and illuminates resultant professional tensions. Using 
the sociology of the professions, the analysis contributes to the understanding of the 
development of pharmacy as a profession and its evolving interprofessional relationship with 
the medical profession. The final section presents the study discussion and conclusion, its 
limitations and scope for further research in this area. 
 
 
The (Re)Professionalisation of Pharmacy Through Healthcare Reform 
 
When considering the status of pharmacy as a profession, it is important to note that pharmacy 
is one of the oldest healing professions and was once held in higher regard. The history of 
pharmacy and the making of medicines can be traced back over 4000 years (Court, 2005), 
during which time great shifts in both medical practice and professional boundaries (see Figure 





Figure 1: The Evolution of Pharmacy  
(Anderson, 2005: p.12) 
 
When reviewing the early history of pharmacy and medicine, the two professions are 
practically inseparable with Spicer-Apothecaries (an early term for pharmacists) not only 
dispensing medicines but also prescribing them (Trease, 1964); a situation which persisted in 
many parts of the world including the British Isles until the end of the 17th century (Homan, 
2005). At this time pharmacy enjoyed a status comparable to medicine through its 
understanding and control over an exclusive field of specialised knowledge concerning the 
compounding and dispensing of medicines. It also had control over remuneration for its 
services, another feature which is attributed to occupational groups that are identified as 
professions.   
 
The history of pharmacy portrays the historical relationship between Apothecaries and 
Physicians as one of ongoing conflict and competition as a result of the skills and service 
overlap of the two professions (Barrett, 1905; Poynter, 1965). The right to prescribe was 
particularly contentious and came to a head in Britain in 1704 in a legal battle in the House of 
Lords (the Rose Case) the outcome of which a ruling that apothecaries could both prescribe 
and dispense medicines (The Worshipful Society of Apothecaries). It was shortly after this 
period that the Society of Apothecaries evolved into general medical practitioners and the 
pharmacy profession grew out of the Association of Chemists and Druggists, which led to the 
formation of the Pharmaceutical Society in 1841. Later the same year they were granted a 
Royal Charter representing the beginnings of modern pharmacy in the UK.  From then onward, 
moves were made to increase the education of pharmacists with statutory qualifications being 
imposed and reinforced through the pharmacy education Act in 1886 (Anderson, 2001). 
Expansion of formal education continued with a degree qualification appearing in the UK in 
1924. By 1948 a three-year honours degree had been introduced at the University of London, 




Alongside these changes, the expansion of the pharmaceutical manufacturing industry also had 
a significant impact on the pharmacy profession. As research within the large drugs companies 
increased, the significance of the traditional compounding role of pharmacists diminished. 
Further, as propriety drugs became widely available at reduced prices, pharmacy’s role in 
production gradually became negligible. As a consequence of these technological and 
economic changes, pharmacists found themselves being viewed as over trained and qualified 
for their role and became labelled as a quasi or marginal occupation (Eaton & Webb, 1979).  
These changes also contributed to the structural fragmentation of the occupational group with 
two principal sectors emerging: private business (retail) and medical (hospital-based) 
pharmacy (Turner, 1995), which in turn are fragmented both vertically and horizontally in the 
form of hospital pharmacists, administrators, industrial chemists and retail pharmacists. Such 
fragmentation made the continued development of a common professional code of practice 
difficult to achieve or sustain.  
 
The social, economic and political contexts in which pharmacy has existed have largely 
developed and shaped the role and practice of pharmacy as it is known today (Anderson, 2005). 
UK hospital pharmacists, in particular, have responded to the existential threat posed by falling 
status, by developing services and clinical skills that strongly supported the activities of the 
medical profession and ensured their continued relevance to the health service (Anderson, 
2005). Indeed, hospital pharmacy has undergone significant development since the 1970s; 
moving from the traditional dispensing role into a clinically oriented service that includes 
medicines management programmes and the writing of discharge prescriptions (Buckley, 
Grime & Blenkinsopp, 2006). The Royal Pharmaceutical Society of Great Britain (RSPGB) 
has actively engaged in professional developments that push the boundaries of the pharmacist’s 
role beyond compounding and dispensing into clinical activities and developed strategies, 
training and services for Pharmacy in a New Age (Holloway, Jewson & Mason, 1986; RPSGB, 
1986, 2002, 2009). 
 
Successive governments also have recognised the potential of pharmacists to contribute to 
more efficient and effective medicines management (DOH,1988). Greater involvement of 
pharmacists in prescribing decisions and practice was deemed essential to the control of 
prescribing costs and ensuring patient safety (Audit Commission 1994), while the Department 
of Health (DOH 1999, p8) observed that ‘pharmacists in all sectors, working as part of the 
clinical team, have an important role in ensuring consistent standards of care across the NHS’. 
In this vein, the NHS Executive initiated reforms which have facilitated an expanded role for 
pharmacists and task redistribution such as the promotion of advisory and healthcare services 
and clinical pharmacy services to support efficient and cost-effective prescribingii, and clinical 
governance (NHS Executive, 1999). For example, an Area Prescribing and Medicines 
Management Committeeiii was established that had the remit to develop and co-ordinate 
strategic medicines management by providing consistent, evidence-based advice for the 
improvement and cost-effectiveness of prescribing across the primary/secondary care interface. 
Such committees worked in conjunction with the National Institute for Health and Care 
Excellence (NICE) and its Scottish equivalents, the Scottish Intercollegiate Guidelines 
Network and the Scottish Medicines Consortiumiv, to develop prescribing guidelines and 
protocolsv for the safe and cost-effective use of medicines (Jackson et.al., 2014).  
 
The (1999) DOH Report on the Review of Prescribing and Supply of Medicines also recognised 
the constraints that had been placed on the professional practice of pharmacy and the waste of 
highly trained human resources that resulted. Its recommendations urged the expansion of 
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supplementary prescribing to include pharmacists for both the betterment of the health service 
and the easing of professional frustration:  
 
‘it is desirable that highly trained health professionals should be able to use their full range of 
skills in the interests of better patient care, the efficient use of resources and enhanced job 
satisfaction (DOH, 1999, p.19).   
 
As the new millennium ensued, a barrage of reports from the DOH and other agencies 
hammered home the need for change. The NHS Improvement Plan, observed that ‘unnecessary 
boundaries exist between the professions which hold back staff from fulfilling their true 
potential’ (DOH, 2000a. p.27) while Pharmacy in the Future bemoaned that ‘pharmacists are 
highly qualified professionals, whose skills the NHS has been under-utilising for too long’ 
(DOH, 2000b, p.9). In 2001 the Audit Commission’s A Spoonful of Sugar argued that pharmacy 
services need to be seen as a ‘core clinical function not a technical support service’ (p.44). A 
Vision for Pharmacy in the New NHS emphatically stated that ‘Pharmacists are probably the 
biggest untapped resource for health improvement’ (DOH, 2003, p.7) and that the ‘value of 
their role within the NHS cannot be overestimated’ (DOH, 2003, p.23). Thus, with drug 
treatments being one of the largest expenditures in the NHS, pharmacists were increasingly 
seen as key players in government drives to push down expenditure, optimise the utilisation of 
scare resources, and promote efficiency and value for money through improving managerial 
capacity, establishing collaborative networks and the redistribution of critical roles such as 
prescribing.vi These messages were strongly supported from within the pharmacy profession 
when the Pharmacists Prescribing Task Group published a report that was closely aligned to 
the government rhetoric (RPSGB, 2002).  
 
Cumulatively, the recommendations outlined above paved the way to a supplementary 
prescribing role being opened to pharmacists in 2004 (Scottish Government, 2004). The 
apparent success of pharmacist supplementary prescribing in improving cost effectiveness and 
patient medicines management then provided further support for the development of 
independent prescribing rights for pharmacists (Cooper et al., 2008), which led to an 
amendment to the Statutory Instruments 2006, No 915, Medicines Order to permit pharmacists 
independent prescribing rights (except for three specific controlled drugs for the treatment of 
addiction) for any condition within their clinical competence (Statutory Instrument, 2006).  
 
The core theme within the reforms outlined above are centred on achieving efficient and cost-
effective medicines management through interprofessional working and task redistribution that 
maximises specialist expertise. The nature of these changes when taken together, are 
considered by some social scientists to be a (re)professionalising opportunity for pharmacy and 
a direct challenge to the autonomy and professional standing of the medical profession through 
the imposition of bureaucratic rule (McKinlay, 1982; Edmunds & Calnan, 2001; McDonald et 
al., 2010). While the medical profession holds the same ideal as government in terms of 
wishing to create and provide an outstanding healthcare system, the perspectives contained 
within the reforms such as prescribing guidelines and protocols that impose autonomy 
constraints and task redistributions that affect their professional boundary are unlikely to go 
uncontested (Britton, 2001; Abraham, 2009; Weiss & Sutton, 2009).   
 
Professional Autonomy and Managerial Logics 
 
The changes highlighted above will now be considered through the application of the sociology 
of the professions. In the study of the concept of ‘profession’, autonomy has been identified as 
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being a central component (Harrison & McDonald, (2003). Indeed, the principle of clinical 
autonomy has permeated the management and organisation of the NHS since its inception and 
the ability to prescribe has long been seen as a marker of the professional power and autonomy 
of the medical profession (Abbott, 1988; Mesler, 1991). The proximity between clinicians and 
the substance prescribed is encapsulated by the use of the word medicine which describes both 
the substance and the profession (Britten, 2001). However, within the deprofessionalisation 
thesis, it is argued that the medical profession is losing its cultural authority in terms of prestige, 
trust and autonomy as a result of political changes, workforce reconfigurations and increased 
awareness and knowledge of the patients which it serves (Harding & Taylor, 1997; Haug, 
1988).  
 
Arguably, the specialist pharmacological training that pharmacists undertake places pharma-
cists as society’s real experts on medicines; providing and ensuring their safe and effective use 
through their information and advice (Britton, 2001). But, as discussed above, pharmacy as a 
health care function has in the past been termed a marginal or quasi-profession due to its ap-
parent inability to promote and control its existence. Traditional professional boundaries and 
territoriality militated against a closer working relationship between pharmacists and clini-
cians, contributing to this marginalisation (Claesson, 1989). Furthermore, Jamous & Peloille 
(1970) with their technicality/indetermination ratiovii, argue that a significant problem for phar-
macy lies within its precise and systematic knowledge base, which is founded on exact science 
that does not allow for a wide range of interpretation and thus leaves little scope for judgement 
or hermeneutics. Finally, pharmacy as a profession had not fully developed a patient counsel-
ling role in its own right. Rather this has been mediated through the medical profession. The 
result is an occupational grouping with a highly developed science in the form of pharmaco-
logical knowledge, but under-developed interpretative skills in relation to patient welfare (Den-
zin & Mettlin, 1968), thus reinforcing the perception of pharmacy as a marginal or quasi-pro-
fession. 
 
Hospital pharmacy as a distinct sub-grouping of general pharmacy, has, on the other hand, 
developed clinically orientated services and a skill set that complements and overlaps the med-
ical profession in a way that challenges the perception of it as a marginal or quasi-profession.  
The potential for this was spotted in the early days of the professionalisation literature when 
Freidson and Lorber (1972) noted that the services of pharmacy were essential to the practice 
of medicine and contended that developments in pharmaceutical services and pharmacist pre-
scribing could potentially threaten the medical profession’s position and lead to inter-profes-
sional conflict. Eaton and Webb (1979) countered that the expansion of clinical pharmacy ac-
tivity into prescribing practice would not necessarily offer much threat in terms of boundary 
encroachment if clinicians delegated some of the tasks involved in prescribing, such as drug 
therapy monitoring and counselling to clinical pharmacists. They further argued that such an 
expansion did not suggest that the dominance of medicine would be threatened but rather that 
it would indicate a renegotiation of order within a limited, predefined area in which clinicians 
retained control over the patient management programme. However, later writers such as Hol-
loway, Jewson & Mason (1986), Elston, (1993) and Weiss and Fitzpatrick (1997) recognised 
that pharmacists increased involvement in clinical activities such as drug history taking, patient 
counselling and prescribing did appear to be boundary encroachment and could be regarded as 
a professionalising strategy and a means to enhance their professional status. Freidson, (1986, 
1988) further contended that the medical profession would be driven to circumscribe the activ-




From this standpoint, it makes sense to examine the effects of managerial logics and workforce 
reconfigurations and their potential impact on professional autonomy. In particular, if manage-
rial logics and workforce reconfigurations are viewed as a form of bureaucratic rule, this then 
raises questions with regard to their potential to undermine of the status of the medical profes-
sion (Allsop, 2006; Harrison & Checkland, (2009). Indeed, Abernethy and Vagnoni (2004) 
argue that managerial logics and workforce reconfigurations challenge the power and auton-
omy of clinicians and their relationship with other healthcare professionals and society. Gray 
and Harrison (2004), further contend that managerial logics, workforce reconfigurations, and 
other systematizations of medical practice can ostensibly be regarded as a government attempt 
to reconfigure aspects of clinical practice into a set of scientific or technical rules which through 
their political legitimacy suppress contestation. Such initiatives, when taken together, are ar-
gued to represent a new form of bureaucracy that is characterised by policies and formal rules 
that increase the level of surveillance and decrease professional autonomy (Harrison, 2003). 
 
It is the effect of the outputs of these policies and rules that are examined here. The problem 
can be seen as one of the weakening of a jusrisdictional boundary; in this case the boundary 
between the medical and pharmaceutical domains and the resultant migration of pharmacists 
into that domain. Abbot (1988, p. 89) has argued that ‘many or most jurisdictions are uniquely 
held’, but the introduction of policy instruments, guidelines and formularies and the use of 
interdisciplinary collaborative groups (e.g. NICE and SIGN) can be seen as the introduction of 
‘boundary objects’ that weaken and mediate the jurisdictional boundary and create boundary 
bridges (see for example Kislov, 2014). Reflecting on the work of Jamous and Peloille (1970) 
these boundary objects do their work by tehnicising and codifying aspects of prescribing 
practice in a way that shifts them from the indeterminate domain of medical (and 





Figure 2: A model of the jurisdictional boundary between Medicine and Pharmacy  
 
From figure 2, each profession has an abstract, indeterminate field of knowledge with an 
overlap at the point of diagnosis/treatment. The training of each group ensures that each has 
some knowledge of the other field, with clinicians traditionally claiming sufficient knowledge 
over the pharmacological field to have primacy over prescribing, a claim that pharmacy found 
hard to resist due to their more limited knowledge of diagnosis. But the introduction of clinical 
guidelines and formularies has reduced the clinicians’ hold over some areas of prescribing 
practice and Jackson et al., (2014) showed that many, particularly junior, clinicians felt that 
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their clinical autonomy (jurisdiction) had been eroded. It is from this standpoint that the 
development of clinical pharmacy is examined.  
 
 
Sources and Research Method 
 
To explore the above issues, this paper reports on a case study of hospital pharmacists 
prescribing in Scotland. The study seeks to locate itself within the management and the control 
of medicines in secondary care and specifically examines the effect of the expansion of 
prescribing into the clinical pharmacy role on the interprofessional relationships and status of 
pharmacy and the medical profession. In particular, there is critical reference to the foundation 
of a profession and role boundaries. As outlined above, the right to prescribing has been a 
hallmark and indicator of the dominance of the medical profession (Abbott, 1988; Mesler, 
1991; MacDonald, 1995). The introduction of pharmacist prescribing supported by external 
forces and organisational structural changes represents a challenge to this professional 
jurisdiction (Abbott, 1988, p.91-6). The central objective of this paper is, therefore, to 
investigate the impact of this challenge to prescribing jurisdiction on the interprofessional 
relationships between hospital clinicians and pharmacists.    
 
The research approach adopted for this study was a qualitative paradigm as it enables the 
examination of structural processes and participants in their daily routines (Schultz, 1967), and 
facilitates an understanding of actions in terms of how and why they occur (Cassel & Symon, 
1994). This approach also provides the flexibility to investigate issues associated with the 
phenomena under study from the participants perspective (Blaikie, 2000). The data was 
gathered over the period 2011-2016 from three NHS Trusts within the central belt of Scotland. 
All three sites provide a comprehensive range of health services including acute and chronic 
hospital services covering a population between 300,000 – 1.2 million with an average staffing 
of between 8,000- 44,000.  Each site also provides hospital pharmacy services. The sites were 
chosen according to accessibility. Ethical approval for the study was granted from the relevant 
NHS Trusts and confidentiality was guaranteed, therefore, no participants or locations are 
specifically identified. The data was gathered from thirty-eight participants using semi-
structured interviews which were designed to tease out the experience, attitudes and 
sensitivities of pharmacists prescribing on their perception of professional status and 
interprofessional relationships. The interview questions were guided by issues identified in 
prior literature and previous studies conducted by the researcher. The study participants 
included three clinical directors, six senior clinicians, seven clinicians, three directorate 
(clinical) pharmacists, four pharmacy managers, nine clinical pharmacists and six pharmacists. 
Appendix 1 provides details on the participants codes, site number and the duration of the 
interviews. Participation in the interviews was entirely on a voluntary basis. Notes were taken 
by the researcher during the interviews and, where permission was granted, the interviews were 
recorded and transcribed.  
 
Following the first batch of six interviews, an initial data analysis was conducted in order that 
any necessary adjustments to the semi structured interview questions could be made, but no 
changes were deemed necessary to the original interview questions. The interview data was 
examined several times to enable familiarity and identification of emergent themes inductively 
(Paterson et al., 2016). To conceptualise the data a simple coding procedure was applied. An 
iterative approach was adopted for the data organising that involved the repeated comparison 
of the data themes to identify similarities and differences which were grouped into appropriate 
descriptive categories (Thomas & Harden, 2007). The recurring themes centred around what 
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constitutes prescribing, prescribing issues and developments, professional status and 
interprofessional relations.   
 
An interpretivist approach was adopted for the data analysis. The interpretative approach seeks 
to ascertain why actors behave in certain ways by unearthing the largely tacit, mutual 
knowledge, symbolic meanings, motives and rules which govern their behaviour (Corbin & 
Strauss, 2008; Blaikie, 2000, p.115). Such an approach offers the possibility to generate an 
understanding of changes in practice from the actor’s perspective and facilitates analysis of 
how this is woven into a wider social framework (Chua, 1986). The primary objective was to 
identify issues and developments that are perceived by the study participants to have 
specifically affected their professional status and interprofessional relationships.  
 
As with other qualitative studies, this study has its limitations which stem from its sample size 
and being restricted to one geographical location, which does not permit generalisations 
(Corbin & Strauss, 2008) on the full impact of managerial logics and workforce reconfiguration 
on the interprofessional relationship and status of the two professions under examination. 
Additionally, the word constraints of the article restricted the scope of background material 
and use of participant views and opinions. As such, extreme care was taken to ensure that the 
most important relevant sources were included in the background material. Likewise, the core 
reflections and exact meaning of the study participants are presented in verbatim. The author 
accepts responsibility for any deficiencies that may appear in this respect.  
 
As one of the first studies to examine the impact of managerial logics and workforce 
reconfiguration on hospital pharmacist prescribing, the study provides a contribution to the 
medicine’s management and the sociology of the profession’s literature demonstrating that 
medical practice can be subjected to rationalisation in the same way as other occupations. 
Furthermore, it sheds light on important issues regarding the interprofessional relationship 
between pharmacists and clinicians and opens up opportunities for more research in this area.  
 
Empirical Results and Reflections 
 
In this section the perceptions and responses of the study participants to pharmacist prescribing 
are put forward. The findings are laid out in two parts. The first part offers insights into the 
pharmacist’s perspective on prescribing, professional judgement and inter-professional 
working. The second part introduces the views and opinions of clinicians on pharmacists 
prescribing, professional knowledge and the impact on interprofessional working and status. 
 
Pharmacist Perspective: Prescribing 
As previously discussed, within the study of the professions and the wider structure of society, 
the ability to prescribe has traditionally been used as an indicator of the professional power and 
autonomy of the medical profession (Abbott, 1988; Mesler, 1991). Indeed, full jurisdiction 
over the right to prescribe has been a defining feature of the medical profession. The Oxford 
Dictionary definition of prescribe is ‘to advise or order the use of a medicine with directions 
for the manner of using it’. A series of events precedes any prescribing decisions. These 
involve, taking note of the patient’s clinical history, making a clinical diagnosis through the 
application of a clinical examination which then leads to a decision on which therapeutic 
treatment is most appropriate. Thus, the prescription is determined by the drawing on and 
application of detailed scientific knowledge and experience as appropriate to the individual 




The interviews opened with a discussion of pharmacist’s perceptions of prescribing and this 
new role which led to some interesting views and opinions as to what constitutes prescribing. 
The evidence presented illustrates that defining prescribing within the hospital setting is not 
clear cut in the minds of pharmacists or perceived as a significant change to aspects of their 
practice.  
 
‘Well it depends on what you consider to be prescribing. We [clinical 
pharmacists] attend the clinical rounds and discuss the patient’s medications in 
relation to their medical condition and are actively involved in determining their 
medications, suggesting the most appropriate medications and checking the 
interactions and such like so through our input into these rounds we were in a 
sense making prescribing decisions it’s just that they [the clinicians] were putting 
pen to paper and not us’. (CP3S1).  
 
A further point that was emphasised was that formal prescriptions (as used in primary care) are 
not utilised within the hospital setting: ‘We don’t use prescriptions like the ones issued by the 
GPs we have patient record cards.’ (CP1S1). These charts are an authorisation to supply and 
to administer medication which was argued is not necessarily a prescription, particularly if the 
medication on the chart is medication that was prescribed by a GP, then it is rather considered 
a transcription. Additionally, it was debated whether or not an omission in the patient’s drug 
chart on admission which was identified and corrected by the pharmacist constituted a 
prescribing decision.  
 
‘I had a patient with a heart condition who was on statins and aspirin 75mg come 
onto the ward, but the aspirin was left off his chart, so I added it on so would that 
count as prescribing?’ (CP9S3). 
 
With regards to prescribing, interestingly more than half of the pharmacist’s respondents did 
not recognise that this was a major change to their activity compared to previous practice, 
observing that ‘we’ve always made prescribing recommendations and added things to patient 
charts if needed, it’s just that now it’s more formal’. (CP2S1).  
 
Professional Judgement, Quality and Safety 
One key feature identified in the role of the prescriber is the demonstration and application of 
professional judgement. Reflecting on the historical role of pharmacists it can be argued that 
pharmacists have held such attributes all along. Indeed, pharmacists today through the 
principles of safe and appropriate production of medicine administration charts laid down by 
the RPSGB (2009) and the General Pharmaceutical Council (2018) still hold the legal right to 
refuse the supply of a substance if their professional judgement determines that it is 
inappropriate or in conflict with the patient’s other medication regime: ‘we can refuse to supply 
a medicine if we believe it inappropriate’. (PM3S2). Several respondents held the view that 
given the need for safe prescribing practice, they were ideally placed to ensure that quality and 
safety is achieved: ‘we have detailed knowledge of medicines, which ones go together, potential 
adverse effects and such like so we are really competent when it comes to safety’ (CP7S3).  
 
Quality and safety have featured centrally throughout the NHS reforms, and have also pervaded 
debates on prescribing practice particularly in terms of competency and the activities of new 
prescribers and as a means of containing and constraining prescribing practice. Key concerns 
for pharmacists were the amount of errors that appeared in the patient drug history charts on 
admission, nurses adding medications on to the patient chart, and the faxed and verbal 
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instructions to the pharmacy all of which are not signed off by a clinician and are clearly in 
breach of ‘Safe Prescribing Practice’ as set down by the medical profession.  
 
‘We deal with prescribing issues on a regular basis, sometimes a patient’s drug 
history is wrong, so we have to change it, or the nursing staff will change it, but 
it can be a few days before the clinician is back on the ward which is a problem 
as the change is not signed off’. (PM2S2). 
 
A report by the Medical Protection agency estimates that “medication errors account for 
approximately 20% of all clinical negligence claims against doctors in both primary and 
secondary care” the cost of which is in the region of £750 million per annum (Medical 
Protection, 2016, p.1). The quote above highlights a problem with clinician prescribing (or lack 
of) in terms of safety which could further justify the extended role of pharmacists into clinical 
areas and prescribing activities and was seen as a positive step by some respondents. ‘Now if 
we see an error we can make the necessary amendment to the patient’s medication regime so 
there are fewer hold ups with getting their medication to them’ (CDP2S2). 
 
Indeed, ensuring quality and safety standards, not just in terms of their own prescribing but 
also that of the clinicians, particularly the junior clinicians, was concern for all of the 
respondents. 
 
‘We also need to be careful and have controls and checks on our own prescribing 
the medics also check what we do’ (CP1S1). 
 
 ‘I feel it’s really important to have clinical pharmacists involved in the 
prescribing decisions, especially when the clinician is still relatively 
inexperienced, having us involved helps with safety and improves the quality of 
patient care’ (CDP1S1). 
 
Within the wider political context of the need to ensure quality and safety, the discourses of 
risk as advocated by Foucault (1977) in his work Discipline and Punish, provide the rationale 
for self-examination and audit as a professional requirement: ‘Keeping abreast of new 
medicines and professional development is all part of the job. We need to engage in this to 
provide a good quality service. It’s also a professional requirement’(CP5S2). Previous 
research such as the work of Leicht & Fennell (1997) on the changing organisational context 
of professional work and prescribing safety (Bradley & Nolan, 2008), note that those who 
refrain from risky behaviour perceive themselves to be more rational and responsible than those 
who do engage in risky activities, which supports pharmacists’ opinions on safe prescribing. 
 
Self-limitation and Interprofessional Working 
The emphasis on developing a culture of safety not only provides a rationale for extending 
prescribing authority to pharmacists but also opens up explicit discussions on the competence 
of all prescribers; clinicians included. The focus of safety and the need to be competent 
promotes a new core professional ideal, particularly for new prescribers and provides a medium 
of constraint on the desire to prescribe and a level of self-limitation:  
 
‘You need be able to justify your prescribing decision, so you need to be aware of 
the clinical guidelines, protocols and up on evidence-based regimes otherwise we 
end up with variations in prescribing practice, which is something we are trying 




As previously noted a common theme that appears within the NHS reforms is the drive towards 
increased collaboration between healthcare professional groups and interprofessional working 
teams (DOH, 2000a, 2000b, 2001,2002, 2003, 2004). Within these reforms, the government 
has mandated a change in the authority to prescribe as exemplified by the introduction of 
pharmacist prescribing into the system. It can be argued that the function of pharmacy in terms 
of the level of attention to prescribing detail and dispensing applied provides a valuable safety 
check on clinical decisions.  
 
‘It makes sense that the person with the most pharmacological knowledge should 
be allowed to prescribe. It not only improves quality and safety but can save 
money … and frees up some of the clinician’s time …’ (CP6S2). 
 
Additionally, pharmacist’s unique competence in terms of their pharmacological expertise and 
focus on safety can arguably provide a key force on any prescribing jurisdictional claim. Such 
attributes also exhort the emphasis on self-limitation on practice and the benefits of 
collaborative teams. It can be further argued that fragmenting the process of prescribing into 
distinct tasks that pull on each individual’s area of competence such drug history taking, 
clinical examination and diagnosis, and treatment decision and monitoring has the potential to 
provide improved patient safety and quality of care through a team approach (Bradley & Nolan, 
2008). While the traditional dominating role of clinician prescribing has been taken for granted, 
the rhetoric of collaborative teams, safety and quality within the managerial logics and NHS 
reforms has exhorted the idea of each professional group with their respective areas of 
competence working together to establish a culture of safety and self-imposed limitations. For 
such teams to be effective cooperation and recognition of professional roles and expertise are 
essential. However, it was evident that the majority of pharmacist believe that their expertise 
and ability to take on a prescribing role is both underestimated and underutilised within the 
hospital setting.  
 
‘Clinicians are reluctant to let go, they see it as us encroaching into their area too 
much … They put up the argument that we are not sufficiently trained but I think 
it’s more than that they are protecting their own area … It’s not good really, we 
could help and support them a lot more’ (CP1S1). 
 
Indeed, more than half of pharmacist respondents were very conscious that some clinicians did 
not consider them to have enough knowledge or expertise to safely prescribe, which for some 
was rather offensive and a cause of tension. It was also noted that some clinicians ignored 
pharmacist’s advice, or overruled their prescribing decisions, thus exercising their dominant 
position. 
 
‘Not all clinicians are on board with us prescribing or making prescribing 
recommendations some think it’s too dangerous for the patients, they’re worried 
that we get it wrong and kill them [patients] (CP7S3). 
 
‘Clinicians don’t always accept our prescribing decisions or advice, this can be 
quite frustrating especially as what they prescribe is not necessarily better or 
more appropriate than what was suggested…sometimes it just feels like they are 




This suggests an element of resistance on the part of clinicians to engage fully with pharmacists 
prescribing and highlights the continuation of the politics of domination and autonomy in the 
medical profession and the difficulties of, and barriers to, interprofessional collaboration. 
 
A point that was evident from discussions with the pharmacist respondents concerned their 
legitimacy to prescribe which, from their point of view, was unquestionable.  
 
‘We are trained on the pharmacological effects of medicines on the body, we study 
physiology and anatomy as part of our training, we discuss medication regimes 
with patients, so we are in some ways better qualified to prescribe especially 
compared to some other supplementary prescribers and junior clinicians’ 
(CP8S3). 
 
Indeed, it is evident from the data that pharmacists in general perceive that they have a 
singular expertise with regards to medicines that is superior to other healthcare 
professionals including the medical profession.  
  
‘We know more about the drug interactions than they do, even before we started 
to prescribe we had cases where we had to step in and block a medication that 
was just wrong for the patient given all their other medications and health 
condition’ (CP7S3). 
 
However, the formalising (the act or writing the prescription) of pharmacist prescribing, and 
the associated responsibility was a concern for virtually all of the pharmacist respondents. 
 
‘It makes you think more seriously about the accountability and consequences of 
what you are prescribing, it’s not like telling the clinician what to prescribe and 
him holding the responsibility, it comes back on me that’s a bit scary so getting 
the right clinical training and keeping abreast of the guidelines is crucial’ 
(CDP2S2). 
 
Despite their overall confidence with pharmacological knowledge another issue that was raised 
by pharmacist respondents, regarding them taking on a prescribing role, concerned the 
diagnosis of the patient’s condition. This was an area where the pharmacists showed the most 
reluctance to engage with independent prescribing. 
 
‘I am not entirely comfortable with conducting clinical examinations. It’s not part 
of our general [degree programme] training. The diagnosis training, we get is 
quite short, so I’m not convinced we have the necessary skills to do this 
competently … It’s one thing the clinician doing the diagnosis and us doing the 
prescribing but even they [clinicians] get it wrong sometimes so we need to be 
very careful’ (CP8S3). 
 
Another went on to state that:  
 
‘At first I tend to casually check with the clinician first for example I’ll say Mrs 
Smith needs medication for eczema I’m going to give her E45 and Betnovate 1 in 
4 cream...It gives him a chance to recommend something else but if he says ok 




It is interesting that even where pharmacists held the authority to prescribe a few (around 10%) 
still sought the clinician’s approval which is not required within the supplementary or 
independent prescribing framework and thus indicates a subordinate position. Such views 
support the theoretical perspective of Friedson’s argument that the success of the medical 
profession to control the healing process was the result of their ability to dominate other 
healthcare groups (Freidson, 1986). Indeed, a third of pharmacist respondents indicated a 
preference for the clinicians to continue with the diagnostic role with the pharmacist doing the 
prescribing and any subsequent drug therapy adjustments. Such a collaborative effort is 
considered to draw on each individual’s expertise and has the potential to improve the overall 
quality of patient care. 
 
‘Clinicians doing the diagnosis and pharmacist doing the prescribing seems the 
obvious way forward and makes perfect sense, it has the potential to improve the 
treatment regimens and reduce errors’ (PM4S3). 
 
Despite the reservations raised above, in general there was a willingness to engage in 
professional developments that open up and push the boundaries of professional activity. The 
expanded role of clinical pharmacists into prescribing activities was perceived by many (three 
quarters) of the respondents as a professional development opportunity and improvement for 
their professional status and self-worth: 
 
 ‘Our involvement in clinical activities and prescribing has been good for us, most 
of the clinicians treat us with more respect now which is great as I feel more 
respected professionally’. (CP1S1).  
 
 ‘It enables us to exercise our knowledge more broadly and it’s beneficial to our 
professional development. The clinicians listen and engage with us more 
too’(CP2S1). 
 
While some reservations over the accountability of prescribing was evident, the majority of 
pharmacists (three quarters) perceived the formalisation of prescribing as an important 
indicator of acknowledgment of their knowledge and expertise which impacted positively on 
their professional status and relationship with the medical profession.  
 
‘I was initially a bit nervous of prescribing but now I’ve been doing it for a while 
I really enjoy it. It’s really tested my professionalism and my relationship with the 
clinicians. It was a bit tense at first, but we have come to appreciate each other’s 
role more I think so we are getting on a lot better’ (CP3S1). 
 
In summary, with regard to pharmacist prescribing, mixed views are held as to what constitutes 
prescribing, with a few reluctantly engaging with it while others embraced the concept fully. 
On the issue of competency to prescribe, the majority of pharmacist’s respondents considered 
their pharmacological expertise alongside their clinical training placed them in an ideal position 
to conduct prescribing tasks. However, concerns were raised over safety and accountability of 
this extended role, particularly when pharmacists were engaging in diagnosis; a procedure that 
many felt they were undertrained to perform with complete confidence. Despite such 
reservations, there was general acknowledgement that the changes had positively impacted on 
the role and status of pharmacists, particularly within the collaborative teams. In the next 




Clinicians Views on Pharmacist Prescribing:  
 
As discussed above, the right to prescribe is a traditional hallmark of the medical profession. 
The opening discussion with clinicians revealed general reservations and concerns over 
pharmacists taking on formal prescribing activities on a number of grounds. Many clinician 
respondents did not feel that such a role was suitable for pharmacists as ‘they do not have the 
relevant diagnostic and patient factor skills that are needed to make safe prescribing decisions 
[Patient factors skills were explained as doctor patient interactions in to getting to know the 
patient]’ (SC3S2). Several respondents also mentioned that the BMA did not approve of this 
extended role for pharmacists and had portrayed it as ‘an irresponsible government initiative 
that’s dangerous for the patients’ (C6S3).  
 
Concerns were also raised by half of clinicians over the type and level of prescribing training 
that was given to pharmacist prescribers as compared to the five or six years of training that 
the medical profession undertake. 
 
 ‘A big concern is their limited prescribing training. Patient safety has to be 
ensured. It’s fair enough to get them to prescribe within limited areas, but the 
more chronic illnesses should be kept to the clinician … They just don’t have the 
diagnostic skills or experience to open this up further’ (C7S3).  
 
Another clinician went on to say ‘I would not be happy to have a pharmacist making the 
prescribing decisions for anyone of my family … It’s just not safe … Diagnosis can be very 
difficult and complex, so you need a lot of skills in this area which are developed from years 
of experience … Pharmacists don’t have this experience’ (SC4S2).  
 
Diagnosis and prescribing would thus appear to be inextricably linked in the mind of some 
respondents. Indeed, around half of clinician respondents made recourse to the level of 
professional training as a justification against pharmacist prescribing, which reflects Abbott’s 
professional archetype that justifies control of a jurisdiction on the grounds of ‘first and 
foremost a right to perform the work as professionals see fit…to exclude other workers [and] 
to dominate public definitions of the tasks concerned’ (Abbott, 1988, p.60). This view however, 
was not held by all of the clinicians.  
 
 ‘Pharmacists are an integral part of our team and provide us with advice on the 
most cost-effective treatments and guidance of the best drug combinations to use 
when we discuss the patient’s medications’(C2S1). 
 
‘Their input to medication regimens can be really useful’ (C5S2). 
 
A feature that regularly appeared within the clinician respondent’s discussions was the issue of 
time. Indeed, all respondents made reference to the amount of time (or lack of) spent with 
patients. A few respondents seemed genuinely open to pharmacist prescribing and viewed it as 
a positive development that could free up some time provided they still retained a level of 
control.  
 
 ‘It frees up some of our time, so we can focus on the more critical patients so in 
that respect it’s good … But we need to be really careful how this is set up and 
make sure that they have the right training and support … and also keep it within 




A senior clinician went on to state that the continuous reforms to the service would likely 
enhance this development further in the future.  
 
 ‘The service is under such financial pressure that we are really overstretched in 
some areas, so we are becoming more reliant on nursing staff and pharmacists to 
help take up some of the burden to free us up a bit so that we can spend more time 
with the chronically ill. It’s challenging for them though as they are being 
expected to do things that they are not always comfortable with. It’s also not so 
good for us as we are losing some of our field to them …  I can’t really see this 
situation getting any better’(CD3S3). 
 
Indeed, the majority of clinician respondents felt that as pharmacists became more involved 
the kind of prescribing activities undertaken by them would expand and thus might impact on 
interprofessional working and the work of clinicians and their role as specialists. 
 
Interprofessional Working and Status 
 
With respect to interprofessional working the data illustrates the importance of the clinician-
pharmacist relationship within the hospital setting and indicates as clinical guidelines, 
protocols and quality standards increase, the power balance between the two groups has the 
potential to shift in a favourable way for pharmacy as a healthcare profession.   
 
‘Giving them prescribing rights has increased their status and their confidence 
they challenge our decisions sometimes and quote the protocols and guidelines to 
us. The clinical pharmacist I work with will really stand her ground on some 
issues’(C5S3).  
 
‘The pharmacist that I work with really pushes me to conform to the prescribing 
guidelines we have some lively debates, but I see her point they are there for a 
reason, so we should stick to them’ (SC2S1) 
 
Pharmacist involvement in prescribing decisions was an area in which several clinicians 
perceived that the status of pharmacists had improved. 
 
‘I think in general this has been a good development for pharmacists. They have 
a much greater input now into clinical decisions and work alongside us and are 
part of the decision-making process so for them this has really helped develop 
their status’ (SC3S2). 
 
Indeed, there was a perception among clinicians (just over half) that the esteem and status of 
the hospital clinician within the last 25 years or so has not only changed vis-à-vis pharmacists 
but also with the populace. Indeed, patient’s perception and trust in the medical profession 
were recognised as not being as deferential to the notion of the clinician as being the expert as 
much as it had been in the past.  
 
‘Patients expect much more they hear about new treatments and demand them … 
some even come to us and tell us what they want and resist no for an answer. In 
such cases we have to work really hard to convince them that what we are giving 




It was however, suggested by threequarters of clinicians that this is one area in which the 
pharmacists could help. Longer consultations with patients, particularly those with chronic 
conditions, were considered to be very important, but the time constraints of the clinicians 
made this difficult to sustain.  
 
‘We increasingly rely on non-medical staff [such as pharmacists] to take up the 
strain and fill in the gaps’ 
 
 ‘Pharmacists have more time to spend with the patients, so they can discuss all 
of the ins and outs of their treatment and reassure the patients that the treatment 
regime is the right and appropriate one for them’ (C4S2).  
 
This would suggest that the clinicians regard the pharmacist as being competent with regard to 
counselling patients and providing a concordat service. However, this rather contradicts the 
previous assertion that pharmacist do not possess the necessary patient factor skills to make 
safe prescribing decisions. 
 
Despite such mixed views over the role of pharmacists in prescribing, a view that featured 
among most hospital clinicians was that, due to the increasing bureaucratic demand and 
controls being imposed within the health service, the power of the medical profession in general 
was declining; perhaps suggesting that the time of the all-powerful hospital clinician may be 
coming to an end. 
 
‘We have significant resource constraints which are a challenge … the guidelines 
and protocols are a means to try and achieve good quality of care in a cost-
effective way, we are expected to follow these as far as possible, but this limits our 
clinical freedom and ability to treat patients the way we want’ (SC4S2). 
 
‘We’re no longer making all the decisions. Regulation is building, more formal 
practices are in place so there’s a greater need to conform ... What is happening 
is everything is becoming more transparent through more controls being imposed 
... We have to work with and take on board the advice of other healthcare workers 
…  pharmacists are an important part of the team we rely on them not just for 
their knowledge of medicines but also for their input into the cost effectiveness of 
the medication regimes’ (C6S3). 
 
The last comment is particularly illuminating as it indicates that the government’s relentless 
attempts to impose managerial logics and workforce reconfigurations into the healthcare 
system are inescapable. In general, the clinician respondents of this study recognised increasing 
incursions into their traditional professional domain by members of the pharmacy profession. 
The reduced dominance and influence as a result of these initiatives has enabled a certain 
amount of re-stratification within the healthcare system to the benefit of the status of the 




This paper considers the impact of attempts to improve efficiency and value for money through 
managerial logics and workforce reconfigurations that maximise specialist expertise such as 
pharmacist prescribing in the hospital setting and examines their effect on the interprofessional 
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relationships of medical professionals and clinical pharmacists. It has been shown that phar-
macy has a long history that overlaps with the medical profession in terms of clinical practice. 
When considering the changing role of pharmacy from its origins through to present day, in 
broad terms the responsibilities and duties of hospital pharmacists today compared to the early 
Spicer-Apothecaries are not significantly different. Indeed, it would appear to have gone full 
circle from prescribing and dispensing for complete patient care through a period of restriction 
to preparation, distribution and procurement back to a clinical function in the form of clinical 
pharmacy which also includes a prescribing role. Such activity echoes the historic function of 
the apothecary and indicates that the profession is in a state of flux (Anderson, 2001, 2005).  
 
The right to prescribe was identified as one of the key hallmarks of the medical profession and 
an aspect of their professional jurisdiction (Larson, 1977). The act of prescribing has been 
shown to be a complex process that involves specific tasks and application of detailed scientific 
clinical knowledge and experience that lead to a decision point. However, this complexity 
opens up the possibility for other health professionals such as pharmacists with relevant clinical 
knowledge to become involved in the process. Pharmacists within secondary care were already 
involved in clinical activities that influenced or controlled prescribing decisions, before 
legislative changes to prescribing authority occurred. This combined with the confusion over 
what constitutes prescribing within the hospital setting (e.g. dose adjustments and the ability 
of pharmacists to refuse the supply of an inappropriate medicine) resulted in some pharmacist 
respondents not considering the expansion into prescribing as a major change to their role. 
Also, in the sites under study, it appears that the development of prescribing activity into the 
clinical pharmacy function involved a slow process of encroachment and delegation, which 
supported the perception that increased prescribing authority is not a major change for hospital 
pharmacists. In this it is clear that the introduction of guidelines, alongside formularies and 
other policy initiatives has created the necessary bridge to overcome the jurisdictional 
boundary. However, the expansion of pharmacists into a prescribing role, while supported by 
government initiatives and the RPSGB has not been a smooth or uncontested transition. Indeed, 
it was clear from the data that pharmacists were very conscious that some clinicians did not 
consider them to have enough knowledge or expertise to safely prescribe. It was reported that 
some clinicians exercised their dominant position by ignoring the pharmacist’s advice or 
overruling their prescribing decisions. For the pharmacists with their strong pharmacological 
expertise and training, this was a source of significant tension.  
 
It is evident that many medical practitioners retain concerns over the extension of prescribing 
authority groups such as pharmacists that sit outside the traditional boundaries of the medical 
profession. Clinician respondents aired concerns about this expanded role on the grounds of 
safety and limited professional training. The lack of pharmacist’s ‘patient factor skills’ were a 
particular concern with regards to prescribing safety. However, the counter to this was a 
recognition amongst clinicians that pharmacists with their specific knowledge base are an 
integral part of the clinical team that supports clinical decision making. In particular, their input 
into clinical decisions and prescribing were considered useful in saving clinicians time, freeing 
them up to spend more time with patients that had more complex needs. Many clinicians regard 
pharmacists as being competent with regard to counselling patients and providing a concordat 
service, which is somewhat contradictory to the safety and patient factor skills argument.  
 
The data indicated that most hospital clinicians are feeling the pressure of increasing 
bureaucratic demands and other controls imposed within the health service. As a result, they 
are increasingly relying on pharmacists to assume tasks that were previously clearly within the 
domain of clinicians, a situation that they perceive will continue and which could possibly 
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expand and impact further on their professional role. Due to increasing financial and time 
pressures and the imposition of quality standards and treatment protocols, clinicians frequently 
succumb to the advice of the clinical pharmacists on prescribing decisions, particularly where 
it is seen as tactful and non-threatening. There remains significant concern that these initiatives 
may undermine clinical autonomy and increase the level of bureaucratic control. Perhaps this 
concern stems from the medical profession’s realisation that the act of prescribing is one area 
in which medical practice can be broken down into distinct technical tasks which can then be 
delegated to other healthcare professionals such as pharmacists. This is of sociological 
importance as it indicates that medical practice can be subjected to rationalisation in the same 
way as other occupations (McKinlay,1982; Ritzer & Walcak, 1982). As such, it is unsurprising 
that segments of the medical profession, including some of this study’s respondents, view the 
expansion of prescribing authority to non-medical healthcare groups such as pharmacists with 
distrust.  
 
Within the sociological literature it is argued that changes to prescribing practice and extending 
prescribing authority to non-medical personnel such as pharmacists would challenge the 
professional control, jurisdiction and status of the medical profession. Indeed, it would appear 
that applying the activity of prescribing as an indicator of medical autonomy, control and 
professional status held by the medical profession, that this has changed. Furthermore, within 
the deprofessionalisation thesis, it is argued that the medical profession is losing its cultural 
authority in terms of prestige and trust as a result of various political changes, increased control, 
awareness and knowledge of the patients which it serves, and professional role reconfigurations 
(Harding & Taylor, 1997). The data suggests a recognition on the clinician’s part that they are 
no longer making all of the decisions, indicating a shift in the level of control. However, in 
contrast, Allsop (2006) argued that the medical profession, rather than being annihilated have 
found ways to accommodate such changes and have succeeded in retaining high status relative 
to other healthcare groups. While this paper does not dispute that opinion, the legislative 
changes in the 2002 Medicines Control Agency consultation paper and the 2004, Scottish 
Government report, which extended supplementary prescribing authority to pharmacists and 
the subsequent 2006, Statutory Instrument, allowing formal independent prescribing by 
pharmacists would appear to have affected the professional control of this aspect of the 
clinician’s work. While pharmacists did not necessarily consider increased prescribing 
authority as a major change, the clinician respondents did regard this as a significant change 
that affected both the pharmacist’s status and their interprofessional relationship with the 
medical profession.   
 
With regard to professional status, Elston, 1993 argues that the function of prescribing at the 
micro level of patient consultations can be viewed as a sign of professional status. While some 
reservations over the accountability of prescribing on the part of pharmacists was evident, the 
majority of pharmacists perceived the formalisation of prescribing as an important indicator of 
acknowledgment of their knowledge and expertise that impacted positively on their 
professional status and relationship with the medical profession. Pharmacists indicated that 
they felt that such activity had enabled them to gain professional status not only within their 
own professional group but with clinicians as well which is also evident in some of the clinician 
respondents’ comments. This was particularly illuminating as it indicates that the medical 
profession in general, recognises a loss of prominence and influence which has enabled a 
certain amount of re-stratification to occur within the healthcare system. Following Haug’s 
(1988) deprofessionalisation argument, pharmacist prescribing represents a loss of a unique 
quality to the medical profession and thus could be considered as deprofessionalising for the 
medical profession and a re-professionalisation of pharmacy. The pharmaceuticalisation of 
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prescribing, which has been encouraged by the government and the Royal Pharmaceutical 
Society Great Britain (2002) potentially may be of more importance to medical sociology than 
its traditional preoccupation with clinical medicine to the exclusion of other occupational 
groups. 
 
It must be acknowledged, however, that from the data produced for this study it is not possible 
to interpret the full extent of the impact of hospital pharmacist prescribing on the status of 
pharmacy as a profession. For instance, it is not clear whether the codification of prescribing 
knowledge genuinely and enduringly creates a shift in the jurisdictional boundary between 
medicine and pharmacy, or whether it merely opens up that space to a range of occupational 
groups such as the nursing profession. It is likely that the state in seeking to reduce the power 
of one profession would be happy to simply substitute increased power for another. Neverthe-
less, important issues regarding the interprofessional relationship between pharmacists and cli-
nicians with regards to the prescribing function have been raised. Indeed, the pivotal role that 
pharmacy can play within medicines management ensures that it will remain as an important 
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Appendix 1: Participant Codes Date Duration 
Clinical Directorate Pharmacist (CDP1 Site 1)  Nov-11 50 mins 
Clinical Directorate Pharmacist (CDP2 Site 2)  Feb-15 45 mins 
Clinical Directorate Pharmacist (CDP3 Site 3)  Mar-16 45 mins 
Pharmacy Manager (PM1 Site 1) Feb-12 40 mins 
Pharmacy Manager (PM2 Site 2) Nov-11 65 mins 
Pharmacy Manager (PM 3 Site 2) Feb-15 50 mins 
Pharmacy Manager (PM4 Site 3) Feb-12 50 mins 
Pharmacy Manager (PM5 Site 3) Mar-16 55 mins 
Clinical Pharmacist (CP1 Site 1) Feb-12 35 mins 
Clinical Pharmacist (CP2 Site 1) Feb-15 55 mins 
Clinical Pharmacist (CP3 Site 1) Mar-16 45 mins 
Clinical Pharmacist (CP4 Site 2) Feb-12 45 mins 
Clinical Pharmacist (CP5 Site 2) Feb-15 45 mins 
Clinical Pharmacist (CP6 Site 2) Feb-15 35 mins 
Clinical Pharmacist (CP7 Site 3) Nov-11 50 mins 
Clinical Pharmacist (CP8 Site 3) Mar-16 40 mins 
Clinical Pharmacist (CP9 Site 3) Mar-16 40 mins 
Pharmacist (P1 Site 1) Feb-12 35 mins 
Pharmacist (P2 Site 2) Feb-15 40 mins 
Pharmacist (P3 Site 3) Mar-16 40 mins 
Clinical Director (CD1 Site 1) Nov-11 60 mins 
Clinical Director (CD2 Site 2) Feb-12 55 mins 
Clinical Director (CD3 Site 3) Mar-16 55 mins 
Senior Clinician (SC1 Site 1) Feb-12 60 mins 
Senior Clinician (SC2 Site 1) Feb-15 35 mins 
Senior Clinician (SC3 Site 2) Nov-11 55 mins 
Senior Clinician (SC4 Site 2) Mar-16 45 mins 
Senior Clinician (SC5 Site 3) Feb-15 30 mins 
Senior Clinician (SC6 Site 3) Mar-16 60 mins 
Clinician (C1 Site 1) Feb-12 55 mins 
Clinician (C2 Site 1) Feb-15 40 mins 
Clinician (C3 Site 1) Mar-16 38 mins 
Clinician (C4 Site 2) Feb-12 30 mins 
Clinician (C5 Site 2) Feb-15 30 mins 
Clinician (C6 Site 3) Nov-11 55 mins 
Clinician (C7 Site 3) Mar-16 65 mins 
 
i Nurse prescribing is outwith the scope of this paper, however the following documents are useful to those 
wishing to investigate nurse prescribing more fully. Neighbourhood nursing: a focus for care (Cumberlege 
Report, 1986) recommended that community nurses should be able to prescribe, as part of their everyday 
nursing care, from a limited list of items. The Crown Report (1989) endorsed nurse prescribing and highlighted 
the circumstances in which it could occur, and a successful private members bill led to the primary legislation 
(Medicinal Products: Prescription by Nurses etc. Act 1992) that provided the power for nurses to prescribe 
available at: https://www.legislation.gov.uk/ukpga/1992/28/pdfs/ukpga_19920028_en.pdf. 
https://www.publichealth.hscni.net/directorate-nursing-and-allied-health-professions/nursing/nurse-prescribing 





iii Area Prescribing and Medicines Management Committees were established for all NHS Trusts. 
iv Each of these committees are made up of lead clinicians and pharmacists from both primary and secondary 
care, commissioning medicines advisors, patient/ pubic representatives and other relevant healthcare support 
staff. 
v Prescribing guidelines and protocols are recommendations for good practice based on the clinical and cost-
effectiveness information for people involved in governing, commissioning, prescribing and making decisions 
about medicines. 
vi Also see Department of Health, 2000a & 2000b, 2003, 2007, 2008. 
vii The I/T ratio was coined by Jamous and Peloille (1970). It refers to an increase in the proportion of elements 
within medical work that can be clearly specified, with a corresponding reduction in the proportion that must be 
left to the judgement of the clinician. 
